18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.

18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.

To evaluate the added value of the application of the liver-specific contrast phase of Gadobenate dimeglumine (Gd-BOPTA) for detection and characterization of liver lesions in 18F-FDG PET/MRI.41 patients with histologically confirmed solid tumors and known / suspected liver metastases or not classif...

Full description

Bibliographic Details
Main Authors: Julian Kirchner, Lino M Sawicki, Cornelius Deuschl, Johannes Grüneisen, Karsten Beiderwellen, Thomas C Lauenstein, Ken Herrmann, Michael Forsting, Philipp Heusch, Lale Umutlu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5500282?pdf=render

Internet

http://europepmc.org/articles/PMC5500282?pdf=render

Similar Items